Swiss Info reports….
The University of Bern has been told it cannot conduct a study on the effects of the regulated sale of cannabis in pharmacies on behalf of the city’s authorities. The Federal Office of Public Health says the legal framework does not exist to authorise such a scientific project.
In May 2017, researchers from the university’s Institute of Social and Preventive Medicine and the Clinical Trials Unit filed a request with the health office for an authorisation to carry out a scientific study on the effects of the regulated sale of cannabis for recreational purposes via pharmacies. It also planned to study the illegal cannabis market in the Swiss capital.
In a written replyexternal link published on Tuesday, the Federal Office of Public Health said the request could not be accepted as “current drugs legislation does not allow the use of cannabis for non-medical reasons”.
“For such a study to be permitted, the law would have to be supplemented by a special legal provision for scientific pilot projects,” it wrote.